News Release

Dr. Ying Luo, CEO of GNI Group Ltd., will be giving a speech on “Moving from Lung Fibrosis to Liver Fibrosis” in the Main Conference Meetings of NASH and Fibrosis event to be held on September 26 and 27, 2017. The NASH and Fibrosis event is a part of 15th Annual Discovery on Target, to be held during the period of September 25 through 29 in Boston MA, USA, sponsored by Cambridge Healthcare Institute.

Cambridge Healthcare Institute’s 15th Annual Discovery on Target will gather over 1,200 drug discovery professionals in Boston. The event brings forth current and emerging “hot” targets, technologies and validation strategies for the development of novel small molecules and biologics.